breast and colon cancer - Nursing Case Study
Pathophysiology
Breast Cancer:
• Primary mechanism: Hormonal influence - Estrogen and progesterone can stimulate breast cell proliferation, leading to mutations and cancerous growths in cells with estrogen receptors (ER-positive tumors).
• Secondary mechanism: Genetic mutations - BRCA1 and BRCA2 gene mutations significantly increase the risk by impairing DNA repair mechanisms, leading to genomic instability and malignancy.
Colon Cancer:
• Primary mechanism: APC gene mutation - Loss of function in the APC tumor suppressor gene leads to unchecked Wnt signaling, causing abnormal cell proliferation and polyp formation, a precursor to cancer.
• Secondary mechanism: Inflammatory processes - Chronic inflammation, as seen in conditions like ulcerative colitis, can cause DNA damage and increase the risk of malignant transformation.
• Key complication: Metastasis - Both cancers can spread to distant organs, complicating treatment and worsening prognosis.
Patient Profile
Demographics:
58-year-old female, retired school teacher
History:
• Key past medical history: Diagnosed with stage II breast cancer two years ago, currently under treatment for stage III colon cancer diagnosed six months ago, hypertension for ten years
• Current medications: Tamoxifen, Capecitabine, Lisinopril, Metformin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent abdominal pain and fatigue
• Key symptoms: Nausea, loss of appetite, changes in bowel habits, shortness of breath on exertion
• Vital signs: Blood pressure 145/90 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 37.8°C, oxygen saturation 93% on room air
Section 1
As the medical team conducts an initial assessment of the 58-year-old female patient, her symptoms and vital signs point to potential complications arising from her ongoing treatment for colon cancer. The abdominal pain and fatigue, coupled with nausea and changes in bowel habits, suggest a possible progression or complication related to her gastrointestinal system. Her vital signs reveal hypertension with a blood pressure of 145/90 mmHg, a heart rate of 105 bpm, and a respiratory rate of 22 breaths per minute, all indicative of physiological stress. The slight fever of 37.8°C and oxygen saturation of 93% on room air further hint at an inflammatory or infectious process.
Upon further investigation, laboratory results reveal an elevated white blood cell count and a marked increase in C-reactive protein (CRP), suggesting an inflammatory response or infection. Liver function tests show elevated liver enzymes, which could indicate hepatic involvement, possibly due to metastasis or liver congestion. Imaging studies, including an abdominal CT scan, identify multiple hepatic lesions consistent with metastatic disease, correlating with the elevated liver enzymes and providing insight into her persistent abdominal pain and fatigue.
The confirmation of hepatic metastasis represents a significant change in the patient's status, necessitating a re-evaluation of her current treatment regimen. The healthcare team must consider the implications of this development on her overall prognosis and the management of her colon cancer. This new complication requires careful clinical reasoning to balance her cancer treatment, manage her hypertension and diabetes, and address the potential for further metastatic spread. The focus will shift towards optimizing symptom control, evaluating the potential for additional systemic therapies, and coordinating palliative care interventions to improve her quality of life.
Section 2
Following the confirmation of hepatic metastasis, the medical team decides to initiate a more aggressive treatment plan aimed at slowing the progression of metastatic colon cancer while managing the patient's symptoms. The oncologist recommends a change in chemotherapy regimen to include a combination of FOLFIRI (leucovorin, fluorouracil, and irinotecan) with bevacizumab, an angiogenesis inhibitor, to target the metastatic lesions in the liver. However, before starting the new regimen, the patient experiences a sudden increase in abdominal distension and tenderness, raising concerns about possible bowel obstruction or perforation, which are known complications in advanced colon cancer cases.
A follow-up abdominal X-ray and CT scan confirm the presence of a partial bowel obstruction, likely caused by tumor growth impinging on the intestinal lumen. This finding necessitates immediate intervention to prevent complete obstruction and potential perforation. The surgical team is consulted to discuss the possibility of a palliative surgical procedure to relieve the obstruction. In the meantime, the patient is placed on IV fluids and electrolyte replacement to manage dehydration and electrolyte imbalances secondary to reduced oral intake and vomiting. Nasogastric tube insertion is considered to decompress the stomach and relieve symptoms of nausea and vomiting.
The patient's clinical status is closely monitored, with a particular focus on her vital signs and laboratory values. Her blood pressure stabilizes slightly with IV fluid resuscitation, though her heart rate remains elevated at 110 bpm, reflecting ongoing physiological stress. Repeat laboratory tests show a slight decrease in white blood cell count but persistently elevated CRP levels, consistent with ongoing inflammation. The healthcare team continues to evaluate her response to these interventions, preparing for potential surgical intervention and adjusting her treatment plan as necessary to manage both her cancer and its complications. This stage in her care emphasizes the importance of timely clinical decisions and multidisciplinary collaboration to optimize her quality of life.
Section 3
As the healthcare team continues to manage the patient's partial bowel obstruction, they closely monitor her clinical status and response to the interventions. Overnight, her abdominal distension decreases slightly with the nasogastric tube decompression, and she reports a modest reduction in nausea. However, in the early morning hours, the nurse notes a change in the patient's vital signs: her heart rate has increased to 120 bpm, and her blood pressure has dropped to 90/60 mmHg, suggesting potential hemodynamic instability. Additionally, the patient appears more lethargic and less responsive, raising concerns about her overall condition.
A repeat laboratory panel shows a further drop in hemoglobin to 8.5 g/dL, alongside a rising lactate level of 3.2 mmol/L, indicating possible tissue hypoperfusion and the risk of developing lactic acidosis. The patient's elevated CRP remains unchanged, signaling persistent inflammation. Given these findings, the team suspects that the partial obstruction may be progressing towards a more complete obstruction or that another complication, such as a microperforation, may be developing.
In response to these changes, the healthcare team convenes an urgent multidisciplinary meeting to reassess the treatment plan. The surgical team advocates for immediate intervention to explore and relieve the bowel obstruction, while the oncology team emphasizes the importance of stabilizing the patient hemodynamically before proceeding. The decision is made to initiate blood transfusion to address the anemia and optimize perfusion, alongside continued IV fluid management to support her blood pressure. The plan is to stabilize the patient sufficiently to proceed with exploratory surgery, with the goal of preventing further deterioration and improving her chances of a positive outcome. This juncture in the patient's care highlights the critical need for timely and coordinated decision-making to manage complex cancer-related complications effectively.
Section 4
As the healthcare team implements the plan, the patient's response to interventions is closely monitored. The blood transfusion is initiated, and over the next few hours, incremental improvements are noted. Her hemoglobin level rises to 9.5 g/dL, and her heart rate stabilizes at 100 bpm, reflecting an improved hemodynamic status. Blood pressure also shows a positive trend, increasing to 105/70 mmHg, suggesting a better perfusion state. The IV fluids continue to support her circulatory volume, and her overall responsiveness improves marginally, as she begins to engage more with the nursing staff, albeit still fatigued.
While these changes indicate some stabilization, the team remains vigilant for further signs of complication, as the patient's abdominal examination reveals persistent tenderness and a slight rebound tenderness, raising the suspicion of ongoing intra-abdominal pathology. Her lactate level, however, remains elevated at 2.9 mmol/L, which keeps the concern for tissue hypoperfusion and possible ischemia at the forefront of clinical considerations. Given these mixed signals, the team decides to proceed with an urgent CT scan of the abdomen to further elucidate the cause of her symptoms and guide the next steps in management.
The CT results reveal significant distension of the bowel with a transition point suggestive of a high-grade obstruction. No overt signs of perforation are noted, but there is mild free fluid present, which could indicate serosal irritation or early inflammation. These findings confirm the need for surgical intervention to resolve the obstruction and prevent further complications. With this information, the surgical team prepares for an expedited exploratory laparotomy, aiming to relieve the obstruction and address any underlying issues, while the oncology team focuses on maintaining optimal perioperative care for this complex patient. This coordinated approach underscores the importance of dynamic clinical reasoning and adaptability in managing multifaceted cancer-related complications.
Section 5
As the surgical team proceeds with the exploratory laparotomy, they encounter a high-grade obstruction caused by an adhesive band from prior abdominal surgeries. Carefully releasing the adhesions, the team successfully decompresses the bowel, restoring intestinal continuity. Intraoperative findings also reveal areas of bowel with compromised perfusion, prompting a limited resection to prevent further ischemic damage. The procedure concludes without complications, and the patient is transferred to the recovery unit for close postoperative monitoring.
In the immediate postoperative period, the patient's vital signs reveal a stable hemodynamic profile. Her heart rate remains at 98 bpm and blood pressure stabilizes at 110/75 mmHg. Despite these encouraging signs, the patient reports increased abdominal pain, now localized and severe. On examination, the surgical incision appears intact, but there is noticeable abdominal distension, raising suspicions of postoperative ileus or potential anastomotic leak. Her white blood cell count has risen to 15,000/µL, and her lactate level is persistently elevated at 3.2 mmol/L, both suggesting an inflammatory response or ongoing tissue stress.
The healthcare team recognizes the importance of differentiating between common postoperative changes and early signs of complications. They initiate supportive measures, including nasogastric decompression and careful fluid management, while preparing for further diagnostic evaluation. A contrast-enhanced CT scan is ordered to assess for signs of anastomotic integrity or other complications. These steps highlight the ongoing need for vigilant monitoring and timely intervention, as the team continues to navigate the complexities of managing this patient's cancer and surgical recovery.